|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
12 December 2020 |
|
Main ID: |
NCT03770923 |
|
Date of registration:
|
07/12/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of Some Drugs on Rheumatoid Arithritis Activity
|
|
Scientific title:
|
Clinical Study Evaluating the Effect of Histamine 1 Receptor Antagonist and Leukotreine Receptor Antagonist on Patients With Rheumatoid Arithritis |
|
Date of first enrolment:
|
October 1, 2018 |
|
Target sample size:
|
75 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT03770923 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
|
Phase:
|
Phase 3
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Fedaa Kotkata, Msc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Tarek M Mostafa, Prof |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Clinical pharmacy Department- Tanta University |
|
|
Name:
|
Fedaa AK Kotkata, Msc |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Clinical pharmacy Department-Tanta University |
|
|
Name:
|
Sahar k Hegazy, Prof |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Head of Clinical Pharmacy Department |
|
|
Name:
|
Sherief Abd-Elsalam, Ph D |
|
Address:
|
|
|
Telephone:
|
00201147773440 |
|
Email:
|
sheriefabdelsalam@yahoo.com |
|
Affiliation:
|
|
|
|
Name:
|
Salwa E Abd El-Ghany, Prof |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Rheumatology Dept. - Tanta University |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Rheumatoid arthritis
Exclusion Criteria:
- liver or renal disease
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Rheumatoid Arthritis
|
|
Intervention(s)
|
|
Drug: Rupatadine
|
|
Drug: Montelukast
|
|
Primary Outcome(s)
|
|
se level of IL-17
[Time Frame: 6 months]
|
|
Secondary ID(s)
|
|
Rheumatoid Arithritis
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|